SEC Form 4 · accession 0001567619-19-006113
CytomX Therapeutics, Inc. · CTMX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lloyd A Rowland
Officer — General Counsel
Period of report
Mar 4, 2019
Accepted (ET)
Mar 5, 2019 · 2:57 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001501989
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 4, 2019 | P | 9,000 | $10.33 | A | 9,979 | D |
Table II — derivative securities
No Table II lines on this filing.